Breaking News
Sort by:
Top Post
Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection
Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]
Aktana Acquires Ople.AI’s Machine Learning Automation Technology
Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced […]
Healx Receives IND and Orphan Drug Designation for Fragile X Clinical Trial
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, is proud […]
Horizon's Saint John Regional Hospital to Become Canada's First to Adopt Subtle Medical's AI Solutions
Subtle Medical, a healthcare technology company using artificial intelligence to improve medical imaging, announced today […]
Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment
Aichi Cancer Center and Fujitsu Limited today announced the development of an AI solution able […]
Roche Announces PathAI Collaboration for Artificial Intelligence-based Digital Pathology Applications for Improved Patient Care
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered an agreement with PathAI, […]
DeepSight ™ Technology Announces $25M Series A Funding Round
DeepSight ™ Technology has announced a $25 million Series A led by Deerfield Management Company, a healthcare investment […]
Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease
Fujitsu Limited today announced that it has started joint clinical research with the University of […]
Oncology is a Major Focus for Many AI Drug Discovery Companies, Reports IDTechEx
The application of artificial intelligence (AI) in the drug discovery process is promising to drastically […]
Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the latest additions to […]
Envisagenics Raises Series A Financing to Scale its AI-powered RNA Splicing Drug Discovery Platform
Envisagenics, an Artificial Intelligence-driven biotechnology company focused on the discovery and development of novel RNA […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more